Fig. 1 · Structure
Documents & Downloads
DATPT
SNX9-p47phox Blocker
DATPT, a SNX9-p47phox blocker, disrupts the interaction between SNX9 and p47phox within the endosomal compartment. This inhibition leads to a reduction in reactive oxygen species and inflammatory cytokine production, demonstrating significant anti-inflammatory and antibacterial properties. DATPT is valuable for research applications related to sepsis and other inflammatory conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2891582-75-3 |
| Applications | SNX9-p47phox Blocker |
| Formula | C24H39ClN6O3 |
| Molecular Weight | 495.06 |
| SMILES | [NH3+]CCOCCOCCNC1=NC(NCC2OCCC2)=NC(C3=CC=C(C=C3)C(C)(C)C)=N1.[Cl-] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.